Literature DB >> 11310521

Evaluation of the antihyperlipidemic properties of dietary supplements.

M F Caron1, C M White.   

Abstract

We reviewed the published literature regarding the antihyperlipidemic effects of dietary supplements. A search of MEDLINE database, EMBASE Drugs and Pharmacology database, and the Internet was performed, and pertinent studies were identified and evaluated. References from published articles and tertiary references were used to gather additional data. Published trials indicate that red yeast rice, tocotrienols, gugulipid, garlic, and soy protein all have antihypercholesterolemic effects. These supplements, as well as omega-3 fatty acids, also have antihypertriglyceridemic effects. In clinical trials none of the agents led to a reduction in low-density lipoproteins greater than 25%, suggesting modest efficacy. When recommending these supplements, clinicians should keep in mind that their long-term safety is not established and patients should be monitored closely.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11310521     DOI: 10.1592/phco.21.5.481.34499

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  3 in total

1.  Omega-3 fatty acids: An update emphasizing clinical use.

Authors:  David Kiefer; Traci Pantuso
Journal:  Agro Food Ind Hi Tech       Date:  2012-07

2.  Combined treatment with Dif1stat and diet reduce plasma lipid indicators of moderate hypercholesterolemia more effectively than diet alone: a randomized trial in parallel groups.

Authors:  Claudia Stefanutti; Fabio Mazza; Antonio Vivenzio; Serafina Di Giacomo; Giuseppina Perrone; Mariarosaria Serra; Antonello Bucci
Journal:  Lipids       Date:  2009-11-13       Impact factor: 1.880

3.  The effect of omega-3 supplementation on androgen profile and menstrual status in women with polycystic ovary syndrome: A randomized clinical trial.

Authors:  Azadeh Nadjarzadeh; Razieh Dehghani Firouzabadi; Niloofar Vaziri; Hoorieh Daneshbodi; Mohammad Hassan Lotfi; Hassan Mozaffari-Khosravi
Journal:  Iran J Reprod Med       Date:  2013-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.